Verve Therapeutics, Inc. ( VERV) - Key Metrics
Stock symbol VERV is outdated, potentially delisted? Maybe it is available on other exchange?
VERV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q1 | $0.37 | -$0.35 | -$0.31 | -$0.33 |
| 2024Q4 | $0.15 | -$0.58 | -$0.47 | -$0.49 |
| 2024Q3 | $0.08 | -$0.59 | -$0.47 | -$0.48 |
| 2024Q2 | $0.08 | -$0.59 | -$0.41 | -$0.42 |
| 2024Q1 | $0.07 | -$0.59 | -$0.52 | -$0.52 |
VERV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q1 | ? | -3.27 |
| 2024Q4 | ? | -2.45 |
| 2024Q3 | ? | -2.04 |
| 2024Q2 | ? | -2.11 |
| 2024Q1 | ? | -5.45 |
VERV
Price: $11.13
52 week price:
Earnings Per Share: -2.11 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 434163
Market Capitalization: 994.0 million